Participants in the 2026 BioCanRx–Cancer Community Partnership Learning Institute are pleased to share their Community Dissemination Report with the oncology patient and research communities, the broader Cancer Community Partnership, and the general public.
The Learning Institute pairs cancer immunotherapy researchers with patient partners to learn from each other’s experiences and cultivate a research ecosystem which hold the patients’ best interest at the forefront.
This report presents key research takeaways alongside participant reflections on the scientific presentations, discussions, and insights shared at the Summit for Cancer Immunotherapy (March 2026).